<!doctype html><html><head><meta charset=utf-8><title>ICU patients 6X more likely to die if poor response to 570,000 IU of Vitamin D – RCT</title>
<link rel=stylesheet href="/css/main.css?v=1748176441"><link rel=stylesheet href="/css/pagination.css?v=1748176441"><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css><script src=https://unpkg.com/lunr/lunr.js></script><script src=https://cdn.jsdelivr.net/npm/pako@2.1.0/dist/pako.min.js></script><script src="/js/search.js?v=1748176441"></script></head><body><div class=top-nav><div class=home-icon><a href=/ title="Go to Home Page"><svg viewBox="0 0 576 512" width="28" height="28"><path d="M575.8 255.5c0 18-15 32.1-32 32.1h-32l.7 160.2c0 2.7-.2 5.4-.5 8.1V472c0 22.1-17.9 40-40 40H456c-1.1.0-2.2.0-3.3-.1-1.4.1-2.8.1-4.2.1H416 392c-22.1.0-40-17.9-40-40V448 384c0-17.7-14.3-32-32-32H256c-17.7.0-32 14.3-32 32v64 24c0 22.1-17.9 40-40 40H160 128.1c-1.5.0-3-.1-4.5-.2-1.2.1-2.4.2-3.6.2H104c-22.1.0-40-17.9-40-40V360c0-.9.0-1.9.1-2.8V287.6H32c-18 0-32-14-32-32.1.0-9 3-17 10-24L266.4 8c7-7 15-8 22-8s15 2 21 7L564.8 231.5c8 7 12 15 11 24z"/></svg></a></div><div class=search-container><div class=search-icon><i class="fas fa-search"></i></div><input type=text id=search-input placeholder=Search... disabled><div id=suggestions class=search-suggestions style=display:none></div><ul id=search-results style=display:none></ul><div id=search-results-panel class=search-results-panel><div class=results-header>Search Results</div><ul id=search-results-panel-list class=results-list></ul></div></div></div><div class=container><div class="content content-full-width" role=main><article><h1>ICU patients 6X more likely to die if poor response to 570,000 IU of Vitamin D – RCT</h1><time>April 1, 2025</time><nav id=TableOfContents><ul><li><ul><li><ul><li><a href=#efficacy-and-safety-of-enteral-supplementation-with-high-dose-vitamin-d-in-critically-ill-patients-with-vitamin-d-deficiency>Efficacy and safety of enteral supplementation with high-dose vitamin D in critically ill patients with vitamin D deficiency</a></li><li><a href=#a-previous-study-by-the-same-authors-found-similar-benefits-to-good-responders-in-icu>A previous study by the same authors found similar benefits to good responders in ICU</a></li></ul></li></ul></li></ul></nav><hr><h4 id=efficacy-and-safety-of-enteral-supplementation-with-high-dose-vitamin-d-in-critically-ill-patients-with-vitamin-d-deficiency>Efficacy and safety of enteral supplementation with high-dose vitamin D in critically ill patients with vitamin D deficiency</h4><p>J Formos Med Assoc. 2025 Apr;124(4):355-360. <a href=https://doi.org/10.1016/j.jfma.2024.05.005>doi: 10.1016/j.jfma.2024.05.005</a></p><p>An-Yi Wang 1, Yu-Chang Yeh 2, Kuang-Hua Cheng 3, Yin-Yi Han 4, Ching-Tang Chiu 2, Chai-Chi Chang 2, I-Ting Wang 5, Anne Chao 6</p><img src=https://d1bk1kqxc0sym.cloudfront.net/attachments/webp/poor-response-increased-death.webp alt=image width=600><p>Background: Vitamin D deficiency is associated with mortality and morbidity in critically ill patients. This study investigated the safety and effectiveness of enteral high-dose vitamin D supplementation in intensive care unit (ICU) patients in Asia.</p><p>Methods: This was a multicenter, prospective, randomized-controlled study. Eligible participants with vitamin D deficiency were randomly assigned to the control or vitamin D supplementation group. In the vitamin D supplementation group, the patients received 569,600 IU vitamin D. The primary outcome was the serum 25(OH)D level on day 7.</p><p>Results: 41 and 20 patients were included in the vitamin D supplementation and control groups, respectively. On day 7, the serum 25(OH)D level was significantly higher in the vitamin D supplementation group compared to the control group (28.5 <span>[IQR: 20.2-52.6]</span> ng/mL and 13.9 <span>[IQR: 11.6-18.8]</span> ng/mL, p &lt; 0.001).</p><p><strong>Only 41.5% of the patients achieved serum 25(OH)D levels higher than 30 ng/mL</strong> in the supplementation group. This increased level was sustained in the supplementation group on both day 14 and day 28. There were no significant adverse effects noted in the supplementation group. Patients who reached a serum 25(OH)D level of >30 ng/mL on day 7 had a significantly lower 30-day mortality rate than did those who did not (5.9% vs 37.5%, p &lt; 0.05).</p><p>Conclusions: In our study, less than half of the patients reached adequate vitamin D levels after the enteral administration of high-dose vitamin D. A reduction in 30-day mortality was noted in the patients who achieved adequate vitamin D levels.</p><p><strong><i class="fas fa-file-pdf" style=margin-right:.3em></i><a href=https://d1bk1kqxc0sym.cloudfront.net/attachments/pdf/high-dose-vitamin-d-in-critically-ill-patients-compresspdf.pdf>Download the PDF from VitaminDWiki</a></strong></p><hr><h4 id=a-previous-study-by-the-same-authors-found-similar-benefits-to-good-responders-in-icu>A previous study by the same authors found similar benefits to good responders in ICU</h4><p><strong><a href=/posts/icu-patients-typically-benefit-from-300-500000-iu-of-vitamin-d-many-studies style=color:red;text-decoration:underline title="This post/category does not exist yet: ICU patients typically benefit from 300-500,000 IU of Vitamin D - many studies">ICU patients typically benefit from 300-500,000 IU of Vitamin D - many studies</a></strong></p><img src=https://d1bk1kqxc0sym.cloudfront.net/attachments/webp/response-to-500k.webp alt=image width=500><pre style=background-color:#e0e0e0;white-space:pre-wrap>
<code class=language-text>
Markdown:
--------
{{&lt; toc &gt;}}

---

#### Efficacy and safety of enteral supplementation with high-dose vitamin D in critically ill patients with vitamin D deficiency

J Formos Med Assoc. 2025 Apr;124(4):355-360. [doi: 10.1016/j.jfma.2024.05.005](https://doi.org/10.1016/j.jfma.2024.05.005)

An-Yi Wang 1, Yu-Chang Yeh 2, Kuang-Hua Cheng 3, Yin-Yi Han 4, Ching-Tang Chiu 2, Chai-Chi Chang 2, I-Ting Wang 5, Anne Chao 6

&lt;img src=&quot;https://d1bk1kqxc0sym.cloudfront.net/attachments/webp/poor-response-increased-death.webp&quot; alt=&quot;image&quot; width=&quot;600&quot;&gt;

Background: Vitamin D deficiency is associated with mortality and morbidity in critically ill patients. This study investigated the safety and effectiveness of enteral high-dose vitamin D supplementation in intensive care unit (ICU) patients in Asia.

Methods: This was a multicenter, prospective, randomized-controlled study. Eligible participants with vitamin D deficiency were randomly assigned to the control or vitamin D supplementation group. In the vitamin D supplementation group, the patients received 569,600 IU vitamin D. The primary outcome was the serum 25(OH)D level on day 7.

Results: 41 and 20 patients were included in the vitamin D supplementation and control groups, respectively. On day 7, the serum 25(OH)D level was significantly higher in the vitamin D supplementation group compared to the control group (28.5 &lt;span&gt;[IQR: 20.2-52.6]&lt;/span&gt; ng/mL and 13.9 &lt;span&gt;[IQR: 11.6-18.8]&lt;/span&gt; ng/mL, p &lt; 0.001). 

 **Only 41.5% of the patients achieved serum 25(OH)D levels higher than 30 ng/mL**  in the supplementation group. This increased level was sustained in the supplementation group on both day 14 and day 28. There were no significant adverse effects noted in the supplementation group. Patients who reached a serum 25(OH)D level of &gt;30 ng/mL on day 7 had a significantly lower 30-day mortality rate than did those who did not (5.9% vs 37.5%, p &lt; 0.05).

Conclusions: In our study, less than half of the patients reached adequate vitamin D levels after the enteral administration of high-dose vitamin D. A reduction in 30-day mortality was noted in the patients who achieved adequate vitamin D levels. 

 **&lt;i class=&quot;fas fa-file-pdf&quot; style=&quot;margin-right: 0.3em;&quot;&gt;&lt;/i&gt;&lt;a href=&quot;https://d1bk1kqxc0sym.cloudfront.net/attachments/pdf/high-dose-vitamin-d-in-critically-ill-patients-compresspdf.pdf&quot;&gt;Download the PDF from VitaminDWiki &lt;/a&gt;** 

---

#### A previous study by the same authors found similar benefits to good responders in ICU

 **&lt;a href=&quot;/posts/icu-patients-typically-benefit-from-300-500000-iu-of-vitamin-d-many-studies&quot; style=&quot;color: red; text-decoration: underline;&quot; title=&quot;This post/category does not exist yet: ICU patients typically benefit from 300-500,000 IU of Vitamin D - many studies&quot;&gt;ICU patients typically benefit from 300-500,000 IU of Vitamin D - many studies&lt;/a&gt;** 

&lt;img src=&quot;https://d1bk1kqxc0sym.cloudfront.net/attachments/webp/response-to-500k.webp&quot; alt=&quot;image&quot; width=&quot;500&quot;&gt;


AST Structure:
-------------
├── DivNode
│   full_match: `{DIV(class=&quot;lefth4&quot;)}{maketoc Title=&quot;&quot;}{DIV}`
│   inner_content: `{maketoc Title=&quot;&quot;}`
│   attrs_dict:
│   │   raw_content: (class=&quot;lefth4&quot;)
│   │   class: lefth4
│   children:
│   ├── MakeTocNode
│   │   full_match: `{maketoc Title=&quot;&quot;}`
│   │   inner_content: ``
│   │   attrs_dict:
│   │   │   raw_content:  Title=&quot;&quot;
│   │   │   Title: ├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!Efficacy and safety of enteral supplementation with high-dose vitamin D in critically ill patients with vitamin D deficiency`
│   inner_content: `Efficacy and safety of enteral supplementation with high-dose vitamin D in critically ill patients with vitamin D deficiency`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `Efficacy and safety of enteral supplementation with high-dose vitamin D in critically ill patients with vitamin D deficiency`
│   │   inner_content: `Efficacy and safety of enteral supplementation with high-dose vitamin D in critically ill patients with vitamin D deficiency`├── TextNode
│   full_match: `\nJ Formos Med Assoc. 2025 Apr;124(4):355-360. `
│   inner_content: `\nJ Formos Med Assoc. 2025 Apr;124(4):355-360. `├── DoiLinkNode
│   full_match: `doi: 10.1016/j.jfma.2024.05.005`
│   inner_content: `10.1016/j.jfma.2024.05.005`├── TextNode
│   full_match: `\nAn-Yi Wang 1, Yu-Chang Yeh 2, Kuang-Hua Cheng 3, Yin-Yi Han 4, Ching-Tang Chiu 2, Chai-Chi Chang 2, I-Ting Wang 5, Anne Chao 6\n\n`
│   inner_content: `\nAn-Yi Wang 1, Yu-Chang Yeh 2, Kuang-Hua Cheng 3, Yin-Yi Han 4, Ching-Tang Chiu 2, Chai-Chi Chang 2, I-Ting Wang 5, Anne Chao 6\n\n`├── ImgNode
│   full_match: `{img type=&quot;attId&quot; attId=&quot;22458&quot; width=&quot;600&quot;}`
│   inner_content: ``
│   attrs_dict:
│   │   raw_content:  type=&quot;attId&quot; attId=&quot;22458&quot; width=&quot;600&quot;
│   │   type: attId
│   │   attId: 22458
│   │   width: 600├── TextNode
│   full_match: `\nBackground: Vitamin D deficiency is associated with mortality and morbidity in critically ill patients. This study investigated the safety and effectiveness of enteral high-dose vitamin D supplementation in intensive care unit (ICU) patients in Asia.\n\nMethods: This was a multicenter, prospective, randomized-controlled study. Eligible participants with vitamin D deficiency were randomly assigned to the control or vitamin D supplementation group. In the vitamin D supplementation group, the patients received 569,600 IU vitamin D. The primary outcome was the serum 25(OH)D level on day 7.\n\nResults: 41 and 20 patients were included in the vitamin D supplementation and control groups, respectively. On day 7, the serum 25(OH)D level was significantly higher in the vitamin D supplementation group compared to the control group (28.5 `
│   inner_content: `\nBackground: Vitamin D deficiency is associated with mortality and morbidity in critically ill patients. This study investigated the safety and effectiveness of enteral high-dose vitamin D supplementation in intensive care unit (ICU) patients in Asia.\n\nMethods: This was a multicenter, prospective, randomized-controlled study. Eligible participants with vitamin D deficiency were randomly assigned to the control or vitamin D supplementation group. In the vitamin D supplementation group, the patients received 569,600 IU vitamin D. The primary outcome was the serum 25(OH)D level on day 7.\n\nResults: 41 and 20 patients were included in the vitamin D supplementation and control groups, respectively. On day 7, the serum 25(OH)D level was significantly higher in the vitamin D supplementation group compared to the control group (28.5 `├── LinkNode
│   full_match: `[IQR: 20.2-52.6]`
│   inner_content: `IQR: 20.2-52.6`
│   url: `IQR: 20.2-52.6`
│   children:
│   ├── TextNode
│   │   full_match: `IQR: 20.2-52.6`
│   │   inner_content: `IQR: 20.2-52.6`├── TextNode
│   full_match: ` ng/mL and 13.9 `
│   inner_content: ` ng/mL and 13.9 `├── LinkNode
│   full_match: `[IQR: 11.6-18.8]`
│   inner_content: `IQR: 11.6-18.8`
│   url: `IQR: 11.6-18.8`
│   children:
│   ├── TextNode
│   │   full_match: `IQR: 11.6-18.8`
│   │   inner_content: `IQR: 11.6-18.8`├── TextNode
│   full_match: ` ng/mL, p &lt; 0.001). \n`
│   inner_content: ` ng/mL, p &lt; 0.001). \n`├── BoldNode
│   full_match: `__Only 41.5% of the patients achieved serum 25(OH)D levels higher than 30 ng/mL__`
│   inner_content: `Only 41.5% of the patients achieved serum 25(OH)D levels higher than 30 ng/mL`
│   children:
│   ├── TextNode
│   │   full_match: `Only 41.5% of the patients achieved serum 25(OH)D levels higher than 30 ng/mL`
│   │   inner_content: `Only 41.5% of the patients achieved serum 25(OH)D levels higher than 30 ng/mL`├── TextNode
│   full_match: ` in the supplementation group. This increased level was sustained in the supplementation group on both day 14 and day 28. There were no significant adverse effects noted in the supplementation group. Patients who reached a serum 25(OH)D level of &gt;30 ng/mL on day 7 had a significantly lower 30-day mortality rate than did those who did not (5.9% vs 37.5%, p &lt; 0.05).\n\nConclusions: In our study, less than half of the patients reached adequate vitamin D levels after the enteral administration of high-dose vitamin D. A reduction in 30-day mortality was noted in the patients who achieved adequate vitamin D levels. \n`
│   inner_content: ` in the supplementation group. This increased level was sustained in the supplementation group on both day 14 and day 28. There were no significant adverse effects noted in the supplementation group. Patients who reached a serum 25(OH)D level of &gt;30 ng/mL on day 7 had a significantly lower 30-day mortality rate than did those who did not (5.9% vs 37.5%, p &lt; 0.05).\n\nConclusions: In our study, less than half of the patients reached adequate vitamin D levels after the enteral administration of high-dose vitamin D. A reduction in 30-day mortality was noted in the patients who achieved adequate vitamin D levels. \n`├── FontNode
│   full_match: `{FONT(size=&quot;17&quot;)}__{ATTACH(inline=&quot;1&quot; id=&quot;22456&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}__{FONT}`
│   inner_content: `__{ATTACH(inline=&quot;1&quot; id=&quot;22456&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}__`
│   attrs_dict:
│   │   raw_content: size=&quot;17&quot;
│   │   size: 17
│   children:
│   ├── BoldNode
│   │   full_match: `__{ATTACH(inline=&quot;1&quot; id=&quot;22456&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}__`
│   │   inner_content: `{ATTACH(inline=&quot;1&quot; id=&quot;22456&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}`
│   │   children:
│   │   ├── AttachNode
│   │   │   full_match: `{ATTACH(inline=&quot;1&quot; id=&quot;22456&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}`
│   │   │   inner_content: `Download the PDF from VitaminDWiki `
│   │   │   attrs_dict:
│   │   │   │   raw_content: (inline=&quot;1&quot; id=&quot;22456&quot; icon=&quot;1&quot;)
│   │   │   │   inline: 1
│   │   │   │   id: 22456
│   │   │   │   icon: 1
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `Download the PDF from VitaminDWiki `
│   │   │   │   inner_content: `Download the PDF from VitaminDWiki `├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!A previous study by the same authors found similar benefits to good responders in ICU`
│   inner_content: `A previous study by the same authors found similar benefits to good responders in ICU`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `A previous study by the same authors found similar benefits to good responders in ICU`
│   │   inner_content: `A previous study by the same authors found similar benefits to good responders in ICU`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── BoldNode
│   full_match: `__((ICU patients typically benefit from 300-500,000 IU of Vitamin D - many studies))__`
│   inner_content: `((ICU patients typically benefit from 300-500,000 IU of Vitamin D - many studies))`
│   children:
│   ├── LocalLinkNode
│   │   full_match: `((ICU patients typically benefit from 300-500,000 IU of Vitamin D - many studies))`
│   │   inner_content: `ICU patients typically benefit from 300-500,000 IU of Vitamin D - many studies`
│   │   page: `ICU patients typically benefit from 300-500,000 IU of Vitamin D - many studies`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `ICU patients typically benefit from 300-500,000 IU of Vitamin D - many studies`
│   │   │   inner_content: `ICU patients typically benefit from 300-500,000 IU of Vitamin D - many studies`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ImgNode
│   full_match: `{img type=&quot;attId&quot; attId=&quot;21282&quot; width=&quot;500&quot;}`
│   inner_content: ``
│   attrs_dict:
│   │   raw_content:  type=&quot;attId&quot; attId=&quot;21282&quot; width=&quot;500&quot;
│   │   type: attId
│   │   attId: 21282
│   │   width: 500├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!VitaminDWiki - ((Vitamin D is needed before many surgeries – many studies and RCTs))`
│   inner_content: `VitaminDWiki - ((Vitamin D is needed before many surgeries – many studies and RCTs))`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `VitaminDWiki - `
│   │   inner_content: `VitaminDWiki - `
│   ├── LocalLinkNode
│   │   full_match: `((Vitamin D is needed before many surgeries – many studies and RCTs))`
│   │   inner_content: `Vitamin D is needed before many surgeries – many studies and RCTs`
│   │   page: `Vitamin D is needed before many surgeries – many studies and RCTs`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D is needed before many surgeries – many studies and RCTs`
│   │   │   inner_content: `Vitamin D is needed before many surgeries – many studies and RCTs`├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!VitaminDWiki - ways to increase the response`
│   inner_content: `VitaminDWiki - ways to increase the response`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `VitaminDWiki - ways to increase the response`
│   │   inner_content: `VitaminDWiki - ways to increase the response`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── BoldNode
│   full_match: `__The following is derived from: ((Reasons for low response to vitamin D))__`
│   inner_content: `The following is derived from: ((Reasons for low response to vitamin D))`
│   children:
│   ├── TextNode
│   │   full_match: `The following is derived from: `
│   │   inner_content: `The following is derived from: `
│   ├── LocalLinkNode
│   │   full_match: `((Reasons for low response to vitamin D))`
│   │   inner_content: `Reasons for low response to vitamin D`
│   │   page: `Reasons for low response to vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Reasons for low response to vitamin D`
│   │   │   inner_content: `Reasons for low response to vitamin D`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── TableNode
│   full_match: `||__Reasons__|__Solutions__\nObese |Give more Vitamin D\nDark Skin| Give more Vitamin D\nKnown poor response%%%((Autistics have half of the response to Vitamin D – RCT Oct 2018|Autism)), ((People with Multiple Sclerosis have blunted responses to Vitamin D supplementation - Jan 2024|MS)), Diabetes, some Cancers|Give more Vitamin D \nFatty liver disease%%%Anemia|Give more%%%Give ((Calcidiol)), (does not need the liver))\nGall-bladder removed|Give ((Water-dispersible forms of vitamins A, D, E and K are better|water dispersable Vitamin D))\nPoor gut%%%Bariatric Surgery|Give ((Gut-Friendly Vitamin D))\nLow Magnesium| Give Magnesium Sulfate%%% (Mg is essential for Vitamin D metabolism) %%%Consider giving Mg if poor 3 day response\nit appears that some people cannot %%% process a single large dose|Spread out the loading dose%%%Such as ((ICU cost reduced by at least 27,000 dollars if get high dose vitamin D in first week - April 2017|50,000 IU daily))\n((No response to vitamin D 7X more likely if poor CYP24A1 or VDBP genes - Feb 2023|Poor gene activations))|Some supplements re-activate some genes||`
│   inner_content: `__Reasons__|__Solutions__\nObese |Give more Vitamin D\nDark Skin| Give more Vitamin D\nKnown poor response%%%((Autistics have half of the response to Vitamin D – RCT Oct 2018|Autism)), ((People with Multiple Sclerosis have blunted responses to Vitamin D supplementation - Jan 2024|MS)), Diabetes, some Cancers|Give more Vitamin D \nFatty liver disease%%%Anemia|Give more%%%Give ((Calcidiol)), (does not need the liver))\nGall-bladder removed|Give ((Water-dispersible forms of vitamins A, D, E and K are better|water dispersable Vitamin D))\nPoor gut%%%Bariatric Surgery|Give ((Gut-Friendly Vitamin D))\nLow Magnesium| Give Magnesium Sulfate%%% (Mg is essential for Vitamin D metabolism) %%%Consider giving Mg if poor 3 day response\nit appears that some people cannot %%% process a single large dose|Spread out the loading dose%%%Such as ((ICU cost reduced by at least 27,000 dollars if get high dose vitamin D in first week - April 2017|50,000 IU daily))\n((No response to vitamin D 7X more likely if poor CYP24A1 or VDBP genes - Feb 2023|Poor gene activations))|Some supplements re-activate some genes`
│   children:
│   ├── TableRowNode
│   │   full_match: `__Reasons__|__Solutions__`
│   │   inner_content: `__Reasons__|__Solutions__`
│   │   children:
│   │   ├── TableCellNode
│   │   │   full_match: `__Reasons__`
│   │   │   inner_content: `__Reasons__`
│   │   │   children:
│   │   │   ├── BoldNode
│   │   │   │   full_match: `__Reasons__`
│   │   │   │   inner_content: `Reasons`
│   │   │   │   children:
│   │   │   │   ├── TextNode
│   │   │   │   │   full_match: `Reasons`
│   │   │   │   │   inner_content: `Reasons`
│   │   ├── TableCellNode
│   │   │   full_match: `__Solutions__`
│   │   │   inner_content: `__Solutions__`
│   │   │   children:
│   │   │   ├── BoldNode
│   │   │   │   full_match: `__Solutions__`
│   │   │   │   inner_content: `Solutions`
│   │   │   │   children:
│   │   │   │   ├── TextNode
│   │   │   │   │   full_match: `Solutions`
│   │   │   │   │   inner_content: `Solutions`
│   ├── TableRowNode
│   │   full_match: `Obese |Give more Vitamin D`
│   │   inner_content: `Obese |Give more Vitamin D`
│   │   children:
│   │   ├── TableCellNode
│   │   │   full_match: `Obese `
│   │   │   inner_content: `Obese `
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `Obese `
│   │   │   │   inner_content: `Obese `
│   │   ├── TableCellNode
│   │   │   full_match: `Give more Vitamin D`
│   │   │   inner_content: `Give more Vitamin D`
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `Give more Vitamin D`
│   │   │   │   inner_content: `Give more Vitamin D`
│   ├── TableRowNode
│   │   full_match: `Dark Skin| Give more Vitamin D`
│   │   inner_content: `Dark Skin| Give more Vitamin D`
│   │   children:
│   │   ├── TableCellNode
│   │   │   full_match: `Dark Skin`
│   │   │   inner_content: `Dark Skin`
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `Dark Skin`
│   │   │   │   inner_content: `Dark Skin`
│   │   ├── TableCellNode
│   │   │   full_match: ` Give more Vitamin D`
│   │   │   inner_content: ` Give more Vitamin D`
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `Give more Vitamin D`
│   │   │   │   inner_content: `Give more Vitamin D`
│   ├── TableRowNode
│   │   full_match: `Known poor response%%%((Autistics have half of the response to Vitamin D – RCT Oct 2018|Autism)), ((People with Multiple Sclerosis have blunted responses to Vitamin D supplementation - Jan 2024|MS)), Diabetes, some Cancers|Give more Vitamin D `
│   │   inner_content: `Known poor response%%%((Autistics have half of the response to Vitamin D – RCT Oct 2018|Autism)), ((People with Multiple Sclerosis have blunted responses to Vitamin D supplementation - Jan 2024|MS)), Diabetes, some Cancers|Give more Vitamin D `
│   │   children:
│   │   ├── TableCellNode
│   │   │   full_match: `Known poor response%%%((Autistics have half of the response to Vitamin D – RCT Oct 2018`
│   │   │   inner_content: `Known poor response%%%((Autistics have half of the response to Vitamin D – RCT Oct 2018`
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `Known poor response`
│   │   │   │   inner_content: `Known poor response`
│   │   │   ├── NewlineNode
│   │   │   │   full_match: `%%%`
│   │   │   │   inner_content: ``
│   │   │   ├── TextNode
│   │   │   │   full_match: `((Autistics have half of the response to Vitamin D – RCT Oct 2018`
│   │   │   │   inner_content: `((Autistics have half of the response to Vitamin D – RCT Oct 2018`
│   │   ├── TableCellNode
│   │   │   full_match: `Autism)), ((People with Multiple Sclerosis have blunted responses to Vitamin D supplementation - Jan 2024`
│   │   │   inner_content: `Autism)), ((People with Multiple Sclerosis have blunted responses to Vitamin D supplementation - Jan 2024`
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `Autism)), ((People with Multiple Sclerosis have blunted responses to Vitamin D supplementation - Jan 2024`
│   │   │   │   inner_content: `Autism)), ((People with Multiple Sclerosis have blunted responses to Vitamin D supplementation - Jan 2024`
│   │   ├── TableCellNode
│   │   │   full_match: `MS)), Diabetes, some Cancers`
│   │   │   inner_content: `MS)), Diabetes, some Cancers`
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `MS)), Diabetes, some Cancers`
│   │   │   │   inner_content: `MS)), Diabetes, some Cancers`
│   │   ├── TableCellNode
│   │   │   full_match: `Give more Vitamin D `
│   │   │   inner_content: `Give more Vitamin D `
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `Give more Vitamin D `
│   │   │   │   inner_content: `Give more Vitamin D `
│   ├── TableRowNode
│   │   full_match: `Fatty liver disease%%%Anemia|Give more%%%Give ((Calcidiol)), (does not need the liver))`
│   │   inner_content: `Fatty liver disease%%%Anemia|Give more%%%Give ((Calcidiol)), (does not need the liver))`
│   │   children:
│   │   ├── TableCellNode
│   │   │   full_match: `Fatty liver disease%%%Anemia`
│   │   │   inner_content: `Fatty liver disease%%%Anemia`
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `Fatty liver disease`
│   │   │   │   inner_content: `Fatty liver disease`
│   │   │   ├── NewlineNode
│   │   │   │   full_match: `%%%`
│   │   │   │   inner_content: ``
│   │   │   ├── TextNode
│   │   │   │   full_match: `Anemia`
│   │   │   │   inner_content: `Anemia`
│   │   ├── TableCellNode
│   │   │   full_match: `Give more%%%Give ((Calcidiol)), (does not need the liver))`
│   │   │   inner_content: `Give more%%%Give ((Calcidiol)), (does not need the liver))`
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `Give more`
│   │   │   │   inner_content: `Give more`
│   │   │   ├── NewlineNode
│   │   │   │   full_match: `%%%`
│   │   │   │   inner_content: ``
│   │   │   ├── TextNode
│   │   │   │   full_match: `Give `
│   │   │   │   inner_content: `Give `
│   │   │   ├── LocalLinkNode
│   │   │   │   full_match: `((Calcidiol))`
│   │   │   │   inner_content: `Calcidiol`
│   │   │   │   page: `Calcidiol`
│   │   │   │   children:
│   │   │   │   ├── TextNode
│   │   │   │   │   full_match: `Calcidiol`
│   │   │   │   │   inner_content: `Calcidiol`
│   │   │   ├── TextNode
│   │   │   │   full_match: `, (does not need the liver))`
│   │   │   │   inner_content: `, (does not need the liver))`
│   ├── TableRowNode
│   │   full_match: `Gall-bladder removed|Give ((Water-dispersible forms of vitamins A, D, E and K are better|water dispersable Vitamin D))`
│   │   inner_content: `Gall-bladder removed|Give ((Water-dispersible forms of vitamins A, D, E and K are better|water dispersable Vitamin D))`
│   │   children:
│   │   ├── TableCellNode
│   │   │   full_match: `Gall-bladder removed`
│   │   │   inner_content: `Gall-bladder removed`
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `Gall-bladder removed`
│   │   │   │   inner_content: `Gall-bladder removed`
│   │   ├── TableCellNode
│   │   │   full_match: `Give ((Water-dispersible forms of vitamins A, D, E and K are better`
│   │   │   inner_content: `Give ((Water-dispersible forms of vitamins A, D, E and K are better`
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `Give ((Water-dispersible forms of vitamins A, D, E and K are better`
│   │   │   │   inner_content: `Give ((Water-dispersible forms of vitamins A, D, E and K are better`
│   │   ├── TableCellNode
│   │   │   full_match: `water dispersable Vitamin D))`
│   │   │   inner_content: `water dispersable Vitamin D))`
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `water dispersable Vitamin D))`
│   │   │   │   inner_content: `water dispersable Vitamin D))`
│   ├── TableRowNode
│   │   full_match: `Poor gut%%%Bariatric Surgery|Give ((Gut-Friendly Vitamin D))`
│   │   inner_content: `Poor gut%%%Bariatric Surgery|Give ((Gut-Friendly Vitamin D))`
│   │   children:
│   │   ├── TableCellNode
│   │   │   full_match: `Poor gut%%%Bariatric Surgery`
│   │   │   inner_content: `Poor gut%%%Bariatric Surgery`
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `Poor gut`
│   │   │   │   inner_content: `Poor gut`
│   │   │   ├── NewlineNode
│   │   │   │   full_match: `%%%`
│   │   │   │   inner_content: ``
│   │   │   ├── TextNode
│   │   │   │   full_match: `Bariatric Surgery`
│   │   │   │   inner_content: `Bariatric Surgery`
│   │   ├── TableCellNode
│   │   │   full_match: `Give ((Gut-Friendly Vitamin D))`
│   │   │   inner_content: `Give ((Gut-Friendly Vitamin D))`
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `Give `
│   │   │   │   inner_content: `Give `
│   │   │   ├── LocalLinkNode
│   │   │   │   full_match: `((Gut-Friendly Vitamin D))`
│   │   │   │   inner_content: `Gut-Friendly Vitamin D`
│   │   │   │   page: `Gut-Friendly Vitamin D`
│   │   │   │   children:
│   │   │   │   ├── TextNode
│   │   │   │   │   full_match: `Gut-Friendly Vitamin D`
│   │   │   │   │   inner_content: `Gut-Friendly Vitamin D`
│   ├── TableRowNode
│   │   full_match: `Low Magnesium| Give Magnesium Sulfate%%% (Mg is essential for Vitamin D metabolism) %%%Consider giving Mg if poor 3 day response`
│   │   inner_content: `Low Magnesium| Give Magnesium Sulfate%%% (Mg is essential for Vitamin D metabolism) %%%Consider giving Mg if poor 3 day response`
│   │   children:
│   │   ├── TableCellNode
│   │   │   full_match: `Low Magnesium`
│   │   │   inner_content: `Low Magnesium`
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `Low Magnesium`
│   │   │   │   inner_content: `Low Magnesium`
│   │   ├── TableCellNode
│   │   │   full_match: ` Give Magnesium Sulfate%%% (Mg is essential for Vitamin D metabolism) %%%Consider giving Mg if poor 3 day response`
│   │   │   inner_content: ` Give Magnesium Sulfate%%% (Mg is essential for Vitamin D metabolism) %%%Consider giving Mg if poor 3 day response`
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `Give Magnesium Sulfate`
│   │   │   │   inner_content: `Give Magnesium Sulfate`
│   │   │   ├── NewlineNode
│   │   │   │   full_match: `%%%`
│   │   │   │   inner_content: ``
│   │   │   ├── TextNode
│   │   │   │   full_match: ` (Mg is essential for Vitamin D metabolism) `
│   │   │   │   inner_content: ` (Mg is essential for Vitamin D metabolism) `
│   │   │   ├── NewlineNode
│   │   │   │   full_match: `%%%`
│   │   │   │   inner_content: ``
│   │   │   ├── TextNode
│   │   │   │   full_match: `Consider giving Mg if poor 3 day response`
│   │   │   │   inner_content: `Consider giving Mg if poor 3 day response`
│   ├── TableRowNode
│   │   full_match: `it appears that some people cannot %%% process a single large dose|Spread out the loading dose%%%Such as ((ICU cost reduced by at least 27,000 dollars if get high dose vitamin D in first week - April 2017|50,000 IU daily))`
│   │   inner_content: `it appears that some people cannot %%% process a single large dose|Spread out the loading dose%%%Such as ((ICU cost reduced by at least 27,000 dollars if get high dose vitamin D in first week - April 2017|50,000 IU daily))`
│   │   children:
│   │   ├── TableCellNode
│   │   │   full_match: `it appears that some people cannot %%% process a single large dose`
│   │   │   inner_content: `it appears that some people cannot %%% process a single large dose`
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `it appears that some people cannot `
│   │   │   │   inner_content: `it appears that some people cannot `
│   │   │   ├── NewlineNode
│   │   │   │   full_match: `%%%`
│   │   │   │   inner_content: ``
│   │   │   ├── TextNode
│   │   │   │   full_match: ` process a single large dose`
│   │   │   │   inner_content: ` process a single large dose`
│   │   ├── TableCellNode
│   │   │   full_match: `Spread out the loading dose%%%Such as ((ICU cost reduced by at least 27,000 dollars if get high dose vitamin D in first week - April 2017`
│   │   │   inner_content: `Spread out the loading dose%%%Such as ((ICU cost reduced by at least 27,000 dollars if get high dose vitamin D in first week - April 2017`
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `Spread out the loading dose`
│   │   │   │   inner_content: `Spread out the loading dose`
│   │   │   ├── NewlineNode
│   │   │   │   full_match: `%%%`
│   │   │   │   inner_content: ``
│   │   │   ├── TextNode
│   │   │   │   full_match: `Such as ((ICU cost reduced by at least 27,000 dollars if get high dose vitamin D in first week - April 2017`
│   │   │   │   inner_content: `Such as ((ICU cost reduced by at least 27,000 dollars if get high dose vitamin D in first week - April 2017`
│   │   ├── TableCellNode
│   │   │   full_match: `50,000 IU daily))`
│   │   │   inner_content: `50,000 IU daily))`
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `50,000 IU daily))`
│   │   │   │   inner_content: `50,000 IU daily))`
│   ├── TableRowNode
│   │   full_match: `((No response to vitamin D 7X more likely if poor CYP24A1 or VDBP genes - Feb 2023|Poor gene activations))|Some supplements re-activate some genes`
│   │   inner_content: `((No response to vitamin D 7X more likely if poor CYP24A1 or VDBP genes - Feb 2023|Poor gene activations))|Some supplements re-activate some genes`
│   │   children:
│   │   ├── TableCellNode
│   │   │   full_match: `((No response to vitamin D 7X more likely if poor CYP24A1 or VDBP genes - Feb 2023`
│   │   │   inner_content: `((No response to vitamin D 7X more likely if poor CYP24A1 or VDBP genes - Feb 2023`
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `((No response to vitamin D 7X more likely if poor CYP24A1 or VDBP genes - Feb 2023`
│   │   │   │   inner_content: `((No response to vitamin D 7X more likely if poor CYP24A1 or VDBP genes - Feb 2023`
│   │   ├── TableCellNode
│   │   │   full_match: `Poor gene activations))`
│   │   │   inner_content: `Poor gene activations))`
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `Poor gene activations))`
│   │   │   │   inner_content: `Poor gene activations))`
│   │   ├── TableCellNode
│   │   │   full_match: `Some supplements re-activate some genes`
│   │   │   inner_content: `Some supplements re-activate some genes`
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `Some supplements re-activate some genes`
│   │   │   │   inner_content: `Some supplements re-activate some genes`

Original Tiki:
-------------
{DIV(class=&quot;lefth4&quot;)}{maketoc Title=&quot;&quot;}{DIV}
---
!!!!Efficacy and safety of enteral supplementation with high-dose vitamin D in critically ill patients with vitamin D deficiency
J Formos Med Assoc. 2025 Apr;124(4):355-360. doi: 10.1016/j.jfma.2024.05.005
An-Yi Wang 1, Yu-Chang Yeh 2, Kuang-Hua Cheng 3, Yin-Yi Han 4, Ching-Tang Chiu 2, Chai-Chi Chang 2, I-Ting Wang 5, Anne Chao 6

{img type=&quot;attId&quot; attId=&quot;22458&quot; width=&quot;600&quot;}
Background: Vitamin D deficiency is associated with mortality and morbidity in critically ill patients. This study investigated the safety and effectiveness of enteral high-dose vitamin D supplementation in intensive care unit (ICU) patients in Asia.

Methods: This was a multicenter, prospective, randomized-controlled study. Eligible participants with vitamin D deficiency were randomly assigned to the control or vitamin D supplementation group. In the vitamin D supplementation group, the patients received 569,600 IU vitamin D. The primary outcome was the serum 25(OH)D level on day 7.

Results: 41 and 20 patients were included in the vitamin D supplementation and control groups, respectively. On day 7, the serum 25(OH)D level was significantly higher in the vitamin D supplementation group compared to the control group (28.5 [IQR: 20.2-52.6] ng/mL and 13.9 [IQR: 11.6-18.8] ng/mL, p &lt; 0.001). 
__Only 41.5% of the patients achieved serum 25(OH)D levels higher than 30 ng/mL__ in the supplementation group. This increased level was sustained in the supplementation group on both day 14 and day 28. There were no significant adverse effects noted in the supplementation group. Patients who reached a serum 25(OH)D level of &gt;30 ng/mL on day 7 had a significantly lower 30-day mortality rate than did those who did not (5.9% vs 37.5%, p &lt; 0.05).

Conclusions: In our study, less than half of the patients reached adequate vitamin D levels after the enteral administration of high-dose vitamin D. A reduction in 30-day mortality was noted in the patients who achieved adequate vitamin D levels. 
{FONT(size=&quot;17&quot;)}__{ATTACH(inline=&quot;1&quot; id=&quot;22456&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}__{FONT}
---
!!!!A previous study by the same authors found similar benefits to good responders in ICU
__((ICU patients typically benefit from 300-500,000 IU of Vitamin D - many studies))__
{img type=&quot;attId&quot; attId=&quot;21282&quot; width=&quot;500&quot;}
---
!!!!VitaminDWiki - ((Vitamin D is needed before many surgeries – many studies and RCTs))
---
!!!!VitaminDWiki - ways to increase the response
__The following is derived from: ((Reasons for low response to vitamin D))__
||__Reasons__|__Solutions__
Obese |Give more Vitamin D
Dark Skin| Give more Vitamin D
Known poor response%%%((Autistics have half of the response to Vitamin D – RCT Oct 2018|Autism)), ((People with Multiple Sclerosis have blunted responses to Vitamin D supplementation - Jan 2024|MS)), Diabetes, some Cancers|Give more Vitamin D 
Fatty liver disease%%%Anemia|Give more%%%Give ((Calcidiol)), (does not need the liver))
Gall-bladder removed|Give ((Water-dispersible forms of vitamins A, D, E and K are better|water dispersable Vitamin D))
Poor gut%%%Bariatric Surgery|Give ((Gut-Friendly Vitamin D))
Low Magnesium| Give Magnesium Sulfate%%% (Mg is essential for Vitamin D metabolism) %%%Consider giving Mg if poor 3 day response
it appears that some people cannot %%% process a single large dose|Spread out the loading dose%%%Such as ((ICU cost reduced by at least 27,000 dollars if get high dose vitamin D in first week - April 2017|50,000 IU daily))
((No response to vitamin D 7X more likely if poor CYP24A1 or VDBP genes - Feb 2023|Poor gene activations))|Some supplements re-activate some genes||
</code>
</pre></article></div></div><script src="/js/lightspa.js?v=1748176441"></script><script>const spa=new LightSPA({mainContentSelector:'[role="main"]',navigationSelector:"[data-spa-nav]"});window.search=new Search({documentsUrl:"/search/search_documents.json.gz?v=1748176441",indexUrl:"/search/search_index.json.gz?v=1748176441"}),document.addEventListener("DOMContentLoaded",function(){function e(e){var t=e.querySelector(".category-expander"),n=e.querySelector(".subcategory-list");e.classList.contains("collapsed")?(e.classList.remove("collapsed"),e.classList.add("expanded"),t.textContent="-",n.style.display="block"):(e.classList.remove("expanded"),e.classList.add("collapsed"),t.textContent="+",n.style.display="none")}document.querySelectorAll(".category-expander").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})}),document.querySelectorAll(".category-name").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})})})</script><script src="/js/toc-sanitizer.js?v=1748176441"></script><script src="/js/search-results-panel.js?v=1748176441"></script><script src="/js/tiki-redirects.js?v=1748176441"></script></body></html>